Wound healing is a complex process, and propolis, a natural resin with antimicrobial, anti-inflammatory, and antioxidant properties, emerges as a promising candidate for its treatment. This systematic review analyzed 26 studies on propolis-functionalized biomaterials. Great diversity was observed in materials and incorporation techniques, including direct blending, surface coating, and nanoencapsulation. Mostly based on polysaccharides like chitosan, pectin, and bacterial cellulose, these formulations showed biocompatibility, biodegradability, and promoted inflammation reduction and tissue repair. In vitro assays confirmed high biocompatibility (>80% cell viability) and antimicrobial activity, while in vivo studies validated regenerative benefits. Despite their potential, marked heterogeneity in propolis composition (intrinsically variable due to its botanical and geographical origin, and processing methods), coupled with diverse concentrations used and the lack of standardization in assessment methods and results reporting, significantly limits cross-study comparability and reproducibility. Overcoming these challenges requires promoting greater standardization in extraction, characterization, and evaluation protocols, including chemical fingerprinting and more detailed and consistent reporting of findings. Despite these limitations, propolis–polysaccharide systems hold strong clinical potential, with further standardization and well-designed preclinical studies being essential for their effective translation, especially in chronic wound management.

Cancer is a complex disease due to its high variability and resistance to conventional treatments. The search for new therapies has prompted the study of less invasive natural sources, such as endophytic bacteria from medicinal plants. Bacillus subtilis is known to produce bioactive metabolites with promising pharmacological properties. This study evaluated the antitumor activity of the endophyte B. subtilis from Ibervillea sonorae against murine L5178Y-R lymphoma cells within in vitro and in vivo models. B. subtilis methanol extract was fractionated in hexane, chloroform, and methanol, with the chloroform partition showing the highest tumor cell growth inhibition (IC₅₀ = 34.62 ± 0.180 µg/mL) and the highest selectivity index (SI = 15.53) when compared with the hexane and methanol partitions. The in vivo study showed that mice treated with 10 mg/kg of the chloroform partition significantly (p < 0.01) reduced the tumor volume and weight without affecting tumor-free body weight. The maximum tolerated dose test indicated that 10 mg/kg was safe and well tolerated. These results indicate that B. subtilis may be a promising source of selective antitumor compounds.

The development of functional biomaterials based on natural polymers has gained increasing relevance due to the growing demand for sustainable and bioactive alternatives for biomedical and technological applications. In this study, chitosan was obtained from shrimp exoskeletons and used to formulate active films enriched with Mexican propolis, aiming to evaluate the influence of the extract on the physicochemical and functional properties of the resulting biomaterial. Propolis was incorporated into the chitosan film-forming solution at a final concentration of 1.0% (v/v). The propolis employed met the requirements of the Mexican Official Standard NOM-003-SAG/GAN-2017 regarding flavonoid content, total phenolic compounds, and antimicrobial activity; additionally, it was evaluated through antioxidant activity, hemolysis, and acute toxicity (LD₅₀) assays to provide a broader biological and safety assessment. The extracted chitosan exhibited a degree of deacetylation of 74% and characteristic FTIR spectral features comparable to those of commercial chitosan, confirming the quality of the obtained polymer. Chitosan–propolis films exhibited antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans, whereas pure chitosan films showed no inhibitory effect. Thermal analyses (TGA/DSC) revealed a slight reduction in thermal stability due to the incorporation of thermolabile polyphenolic compounds, along with increased thermal complexity of the system. SEM observations demonstrated reduced microbial adhesion and marked morphological damage in microorganisms exposed to the functionalized films. Overall, the incorporation of Mexican propolis enabled the development of a hybrid biomaterial with enhanced antimicrobial performance and potential application in wound dressings and bioactive coatings.

Persistent endodontic infections are frequently associated with Enterococcus faecalis, a microorganism capable of penetrating dentinal tubules and surviving conventional disinfection procedures. This in vitro study evaluated the antimicrobial activity of Chihuahuan propolis against E. faecalis using planktonic and intratubular infection models. Propolis extract was tested at concentrations of 15, 35, and 70 mg/mL and compared with triple antibiotic paste (TAP) as a clinically relevant intracanal medicament. Antimicrobial efficacy was assessed by disk diffusion, minimum inhibitory concentration (MIC), colony-forming unit (CFU) reduction in infected dentinal tubules, and scanning electron microscopy (SEM). Chihuahuan propolis exhibited concentration-dependent antimicrobial activity, with a MIC of 17.5 mg/mL. In the intratubular model, propolis at 70 mg/mL achieved a CFU reduction comparable to TAP after seven days of application. SEM analysis confirmed a marked reduction of bacterial colonization within dentinal tubules. Within the limitations of this in vitro, monoespecies model, Chihuahuan propolis demonstrated antimicrobial efficacy against E. faecalis comparable to TAP, supporting its further investigation as a potential non-antibiotic intracanal medicament.

Background/Objectives: Second-degree burns require strategies that address microbial contamination, oxidative stress, exudate, and tissue repair. This study aimed to develop and evaluate a marine-derived chitosan hydrogel incorporating ethanolic extract of propolis (EEP) from Chihuahua, Mexico, for second-degree burn management. Methods: EEP was characterized using parameters established in NOM-003-SAG/GAN-2017 and complementary biological assays. Chitosan hydrogels containing 1%, 3%, and 5% (w/w) EEP were evaluated for physicochemical properties, swelling, mass loss, flavonoid release, antioxidant activity, antimicrobial performance, and cell viability. The 1% EEP hydrogel was further evaluated in a murine second-degree burn model. Results: Chihuahua propolis exhibited high phenolic (27.42 ± 2.53%) and flavonoid (9.23 ± 0.314%) contents. EEP incorporation modified the chitosan matrix, providing high swelling capacity, increased structural persistence, sustained flavonoid release for 72 h, and radical-scavenging activity for 96 h. Antimicrobial activity was concentration-dependent, with the 5% EEP hydrogel reducing recoverable Escherichia coli counts below the detection limit (<10² CFU/mL). However, EEP-containing hydrogels reduced NIH-3T3 viability below the 70% ISO 10993-5 threshold under static extraction conditions. At 144 h, the 1% EEP hydrogel produced greater wound contraction than silver sulfadiazine (p = 0.021), although it did not differ significantly from the propolis-free chitosan hydrogel or untreated control. Qualitative histological assessment showed features consistent with early tissue repair, with cutaneous appendages observed in several sections from the 1% EEP group. Conclusions: Chihuahua propolis-loaded chitosan hydrogels showed promising physico-chemical, release, antioxidant, antimicrobial, and short-term in vivo findings. The in vitro reduction in metabolic activity observed under static extraction conditions warrants further evaluation using physiologically relevant exposure models, extended follow-up, and comprehensive safety assessment.